Astrocytic GPR55 receptors promote glycolysis.

CED Clinical Relevance  #62Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely.
🔬 Evidence Watch  |  CED Clinic
Journal Journal of cannabis research
Study Type Clinical Study
Population Human participants
Why This Matters

This item covers developments relevant to cannabis medicine and clinical practice. Clinicians monitoring evidence in this area should review the source material.

Clinical Summary

The endocannabinoid system is closely associated with systemic and cellular energy metabolism in mammals. We previously demonstrated that the cannabinoid receptors CB Acute hippocampal and cortical slices and primary astrocytic cultures from C57BL/6 mice and Wistar rats were used. Quantitative polymerase chain reaction (qPCR) was used to assess qPCR analysis revealed that Our findings reveal a novel role for GPR55 in astrocytes. By enhancing glycolytic activity in these cells, GPR55 is likely poised to support, even if indirectly, the energy demands of synaptic transmission. The online version contains supplementary material available at 10.1186/s42238-026-00407-x.

Dr. Caplan’s Take

“This is a development worth tracking. The clinical implications will become clearer as more evidence accumulates.”

Clinical Perspective
🧠 Clinicians should review this item in the context of their current practice and patient population.

💬 Join the Conversation

Have a question about how this applies to your situation? Ask Dr. Caplan →

Want to discuss this topic with other patients and caregivers? Join the forum discussion →

FAQ

This study item was assembled from normalized source metadata and pipeline scoring.







Physician-Led, Whole-Person Care
A doctor who takes the time to truly understand you.
Personal care that starts with listening and is guided by experience and ingenuity.
Health, Longevity, Wellness
One-on-One Cannabis Guidance
Metabolic Balance